Wendler, J., Fox, C.P., Valk, E., Steinheber, C., Fricker, H., Isbell, L.K., Neumaier, S., Okosun, J., Scherer, F.P., Ihorst, G., Cwynarski, K., Schorb, E. und Illerhaus, G. (2022) Optimizing MATRix as remission induction in PCNSL: de-escalated induction treatment in newly diagnosed primary CNS lymphoma [cd]. Freiburg: Universität. doi:10.1186/s12885-022-09723-w.

Wendler, Julia, Christopher P. Fox, Elke Valk, Cora Steinheber, Heidi Fricker, Lisa K. Isbell, Simone Neumaier, Jessica Okosun, Florian Paul Scherer, Gabriele Ihorst, Kate Cwynarski, Elisabeth Schorb, und Gerald Illerhaus. Optimizing MATRix as remission induction in PCNSL: de-escalated induction treatment in newly diagnosed primary CNS lymphoma. Cd. Freiburg: Universität, [2022?], Freiburg: Universität, [2022?]. https://doi.org/10.1186/s12885-022-09723-w.

Wendler, J., Fox, C. P., Valk, E., Steinheber, C., Fricker, H., Isbell, L. K., Neumaier, S., Okosun, J., Scherer, F. P., Ihorst, G., Cwynarski, K., Schorb, E., & Illerhaus, G. (ca. 2022). Optimizing MATRix as remission induction in PCNSL: de-escalated induction treatment in newly diagnosed primary CNS lymphoma [Cd]. Universität. https://doi.org/10.1186/s12885-022-09723-w

Wendler, J., C. P. Fox, E. Valk, C. Steinheber, H. Fricker, L. K. Isbell, S. Neumaier, J. Okosun, F. P. Scherer, G. Ihorst, K. Cwynarski, E. Schorb, und G. Illerhaus. Optimizing MATRix as remission induction in PCNSL: de-escalated induction treatment in newly diagnosed primary CNS lymphoma. cd, Universität, 2022, https://doi.org/10.1186/s12885-022-09723-w.

WENDLER, Julia, Christopher P. FOX, Elke VALK, Cora STEINHEBER, Heidi FRICKER, Lisa K. ISBELL, Simone NEUMAIER, Jessica OKOSUN, Florian Paul SCHERER, Gabriele IHORST, Kate CWYNARSKI, Elisabeth SCHORB und Gerald ILLERHAUS, 2022. Optimizing MATRix as remission induction in PCNSL: de-escalated induction treatment in newly diagnosed primary CNS lymphoma. Freiburg: Universität